Promethera Biosciences Competitors and Similar CompaniesClear all

Intercept Pharmaceuticals's competitors and similar companies include Gilead Sciences and Genfit.

	Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.	Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.	Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
Founding Date	Founding Date 2002	Founding Date 1987	Founding Date 1999
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Manufacturing & Industrial biotech clinical research drug development pharma	Tags Healthcare biotech drug development medical diagnostics pharma
Locations	Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more	Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more	Locations Loos, FR HQ Cambridge, US
Employees	Employees 58321% increase	Employees 18,0006% increase	Employees 180
Valuation ($)	Valuation ($) 794.7 m	Valuation ($) 110.5 b	Valuation ($) 280.8 m
Financial
Revenue (est.)	Revenue (est.) $285.7m (FY, 2022)	Revenue (est.) $29.4b (FY, 2025)	Revenue (est.) €65.4m (FY, 2025)
Cost of goods	Cost of goods $984k (FY, 2022)	Cost of goods $6.2b (FY, 2025)	Cost of goods €302k (FY, 2025)
Gross profit	Gross profit $284.7m (FY, 2022)	Gross profit $23.2b (FY, 2025)	Gross profit €70.8m (FY, 2025)
Net income	Net income $221.8m (FY, 2022)	Net income $8.5b (FY, 2025)	Net income (€86m) (FY, 2025)